Go to main contentsGo to search barGo to main menu
Tuesday, July 8, 2025 at 12:37 AM
Ad

L E T T E R TO THE EDITOR

Dear Editor,

Mental Health Awareness Month in Nevada is a time to push forward — not fall behind. Expanding access to care and encouraging open conversation is only part of the picture. The other piece is making sure future mental health treatments actually reach the patients who need them.

With the Trump administration’s recent executive order comes a lot of concern that innovation could be at risk. This order would base our drug prices on countries that use strict pricing models and often limit or delay access to modern therapies. If we copy those systems, it will be harder to bring future mental health treatments to patients in Nevada and across the country, as investments will be severely depleted.

Additionally, the executive order doesn’t listen to the true concerns of patients. The biggest drivers of patient frustration aren’t always visible. PBMs operate in the background, but their decisions shape what gets covered and how much it costs. Until that’s addressed, no pricing reform will deliver the stability patients are looking for.

Nevada should focus on solutions that protect innovation and make care more stable for those who depend on it. That starts by moving past MFN and toward reforms to PBMs.

Sincerely,
Denise Abbey, LCSW, QMHP

May 27, 2025

 

 

 

More about the author/authors:
Share
Rate

Comment

Comments

C
Carl C. Hagen 06/23/2025 07:47 AM
What are MFNs and PBMs ?? ............................ From the editor: This is a very good question and we apologize for not catching that wasn't in there. We reached out to the writer/submitter and got this info back...hope it's helpful. PBM: Pharmacy Benefit Managers are pharmacies that are owned by insurance companies. (CVS is one.) They negotiate with drug makers to get reduced pricing for medications, but they historically have not passed along those savings to patients. https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf MFN: Most Favored Nation pricing is a policy that means a country agrees to offer the same trade concessions (like tariffs or price reductions) to all member nations of the World Trade Organization (WTO). When applied to pharmaceuticals, it could disrupt global access, deter innovation, and obscure the deeper systemic issues in American health care. https://petrieflom.law.harvard.edu/2025/05/22/the-global-risks-of-americas-most-favored-nation-drug-pricing-policy/

July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 1
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 2
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 3
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 4
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 5
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 6
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 7
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 8
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 9
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 10
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 11
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 12
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 13
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 14
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 15
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 16
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 1Page no. 1
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 2Page no. 2
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 3Page no. 3
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 4Page no. 4
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 5Page no. 5
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 6Page no. 6
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 7Page no. 7
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 8Page no. 8
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 9Page no. 9
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 10Page no. 10
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 11Page no. 11
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 12Page no. 12
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 13Page no. 13
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 14Page no. 14
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 15Page no. 15
July 4, 2025 -Fallon Gears Up for a “Bee-autiful”  - page 16Page no. 16
COMMENTS
Comment author: Mike HinzComment text: I knew Sam as a member of our church growing up. He always had a warm smile, a kind word, and a great sense of humor! He will be great missed!Comment publication date: 7/2/25, 11:57 AMComment source: Obituary -- Samuel Bruce WickizerComment author: Mike HinzComment text: Great teacher, great coach, but even a better person!!! Rest in peace Mr. BeachComment publication date: 7/2/25, 11:53 AMComment source: Obituary -- Jack Victor Beach, Jr.Comment author: Mike HinzComment text: I had Mrs Hedges for First Grade at Northside Elementary in 1969. I still, to this day, remember her as a wonderful teacher…one of my favorites!!Comment publication date: 7/2/25, 11:29 AMComment source: Obituary - Nancy Marie Hedges C Comment author: Carl C. HagenComment text: What are MFNs and PBMs ?? ............................ From the editor: This is a very good question and we apologize for not catching that wasn't in there. We reached out to the writer/submitter and got this info back...hope it's helpful. PBM: Pharmacy Benefit Managers are pharmacies that are owned by insurance companies. (CVS is one.) They negotiate with drug makers to get reduced pricing for medications, but they historically have not passed along those savings to patients. https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf MFN: Most Favored Nation pricing is a policy that means a country agrees to offer the same trade concessions (like tariffs or price reductions) to all member nations of the World Trade Organization (WTO). When applied to pharmaceuticals, it could disrupt global access, deter innovation, and obscure the deeper systemic issues in American health care. https://petrieflom.law.harvard.edu/2025/05/22/the-global-risks-of-americas-most-favored-nation-drug-pricing-policy/Comment publication date: 6/23/25, 7:47 AMComment source: L E T T E R TO THE EDITOR
SUPPORT OUR WORK